GtCCR4 gene therapy (OiDE OptoEye)

N/A

Report date: 2024/06/12 15:33:20

Base Information

Drug NameGtCCR4 gene therapy (OiDE OptoEye)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transferenceCation channel rhodopsin 4 modulators
TargetsCation channel rhodopsin 4
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNagoya Institute of Technology
China Registration ClassN/A

Develop Information

Active CompaniesOiDE OptoEye Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A